166 related articles for article (PubMed ID: 29042987)
21. YAP/TAZ Are Essential for TGF-β2-Mediated Conjunctival Fibrosis.
Futakuchi A; Inoue T; Wei FY; Inoue-Mochita M; Fujimoto T; Tomizawa K; Tanihara H
Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):3069-3078. PubMed ID: 30025139
[TBL] [Abstract][Full Text] [Related]
22. Molecular dynamics simulations study of influence of Tyr422Ala mutation on transcriptional enhancer activation domain 4 (TEAD4) and transcription co-activators complexes.
Niu RJ; Zheng QC; Zhang HX
J Theor Biol; 2019 Jul; 472():27-35. PubMed ID: 30978352
[TBL] [Abstract][Full Text] [Related]
23. YAP/TAZ Activation as a Target for Treating Metastatic Cancer.
Warren JSA; Xiao Y; Lamar JM
Cancers (Basel); 2018 Apr; 10(4):. PubMed ID: 29642615
[TBL] [Abstract][Full Text] [Related]
24. Verification of osteoblast differentiation on airborne-particle abrasion, large-grit, acid-etched surface of titanium implants regulated by yes-associated protein and transcriptional coactivator with PDZ-binding motif.
Wei T; Li J; Sun H; Jiang M; Yang Y; Luo X; Liu T
J Oral Sci; 2019 Aug; 61(3):431-440. PubMed ID: 31327805
[TBL] [Abstract][Full Text] [Related]
25. Cerebral Cavernous Malformation 1 Determines YAP/TAZ Signaling-Dependent Metastatic Hallmarks of Prostate Cancer Cells.
Park S; Lee HY; Kim J; Park H; Ju YS; Kim EG; Kim J
Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33807895
[TBL] [Abstract][Full Text] [Related]
26. AMOTL2 interaction with TAZ causes the inhibition of surfactant proteins expression in lung cells.
Lucci V; Di Palma T; D'Ambrosio C; Scaloni A; Zannini M
Gene; 2013 Oct; 529(2):300-6. PubMed ID: 23911299
[TBL] [Abstract][Full Text] [Related]
27. Downregulation of YAP inhibits proliferation and induces apoptosis in Eca-109 cells.
Cui M; Li Z
Exp Ther Med; 2018 Jan; 15(1):1048-1052. PubMed ID: 29403552
[TBL] [Abstract][Full Text] [Related]
28. CLDN18.1 attenuates malignancy and related signaling pathways of lung adenocarcinoma in vivo and in vitro.
Luo J; Chimge NO; Zhou B; Flodby P; Castaldi A; Firth AL; Liu Y; Wang H; Yang C; Marconett CN; Crandall ED; Offringa IA; Frenkel B; Borok Z
Int J Cancer; 2018 Dec; 143(12):3169-3180. PubMed ID: 30325015
[TBL] [Abstract][Full Text] [Related]
29. Relationship between Keloid Formation and YAP/TAZ Signaling.
Aramaki-Hattori N; Okabe K; Hamada M; Takato T; Kishi K
Plast Reconstr Surg Glob Open; 2017 Jun; 5(6):e1357. PubMed ID: 28740772
[TBL] [Abstract][Full Text] [Related]
30. Deubiquitinase JOSD2 stabilizes YAP/TAZ to promote cholangiocarcinoma progression.
Qian M; Yan F; Wang W; Du J; Yuan T; Wu R; Zhao C; Wang J; Lu J; Zhang B; Lin N; Dong X; Dai X; Dong X; Yang B; Zhu H; He Q
Acta Pharm Sin B; 2021 Dec; 11(12):4008-4019. PubMed ID: 35024322
[TBL] [Abstract][Full Text] [Related]
31. Epithelioid Hemangioendothelioma as a Model of YAP/TAZ-Driven Cancer: Insights from a Rare Fusion Sarcoma.
Lamar JM; Motilal Nehru V; Weinberg G
Cancers (Basel); 2018 Jul; 10(7):. PubMed ID: 29996478
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of TAZ promotes cell proliferation, migration and epithelial-mesenchymal transition in ovarian cancer.
Chen G; Xie J; Huang P; Yang Z
Oncol Lett; 2016 Sep; 12(3):1821-1825. PubMed ID: 27588129
[TBL] [Abstract][Full Text] [Related]
33. Epithelial Expression of YAP and TAZ Is Sequentially Required in Lung Development.
Isago H; Mitani A; Mikami Y; Horie M; Urushiyama H; Hamamoto R; Terasaki Y; Nagase T
Am J Respir Cell Mol Biol; 2020 Feb; 62(2):256-266. PubMed ID: 31486675
[TBL] [Abstract][Full Text] [Related]
34. Central role of mTORC1 downstream of YAP/TAZ in hepatoblastoma development.
Liu P; Calvisi DF; Kiss A; Cigliano A; Schaff Z; Che L; Ribback S; Dombrowski F; Zhao D; Chen X
Oncotarget; 2017 Sep; 8(43):73433-73447. PubMed ID: 29088718
[TBL] [Abstract][Full Text] [Related]
35. Neuromedin U contributes to radiation resistance in colorectal cancer via YAP/TAZ signaling activation.
Sim MK; Park JE; Kim SR; Lee J; Kim EJ; Kim Y; Shin US; Kim H; Kim KS
Oncol Rep; 2023 Oct; 50(4):. PubMed ID: 37594135
[TBL] [Abstract][Full Text] [Related]
36. YAP/TAZ Signaling as a Molecular Link between Fibrosis and Cancer.
Noguchi S; Saito A; Nagase T
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30463366
[TBL] [Abstract][Full Text] [Related]
37. New insights into YAP/TAZ nucleo-cytoplasmic shuttling: new cancer therapeutic opportunities?
Shreberk-Shaked M; Oren M
Mol Oncol; 2019 Jun; 13(6):1335-1341. PubMed ID: 31050214
[TBL] [Abstract][Full Text] [Related]
38. Transcriptional co-activator with PDZ-binding motif overexpression promotes cell proliferation and transcriptional co-activator with PDZ-binding motif deficiency induces cell cycle arrest in neuroblastoma.
Yang L; Huang M; Tan J; Hou J; He J; Wang F; Cui H; Yi L
Oncol Lett; 2017 Jun; 13(6):4295-4301. PubMed ID: 28599430
[TBL] [Abstract][Full Text] [Related]
39. HIF-1
Abudoukerimu A; Hasimu A; Abudoukerimu A; Tuerxuntuoheti G; Huang Y; Wei J; Yu T; Ma H; Yimiti D
J Oncol; 2022; 2022():3814809. PubMed ID: 35664561
[TBL] [Abstract][Full Text] [Related]
40. Curcumin Inhibits the Tumorigenesis of Breast Cancer by Blocking Tafazzin/Yes-Associated Protein Axis.
Shen Y; Han Z; Liu S; Jiao Y; Li Y; Yuan H
Cancer Manag Res; 2020; 12():1493-1502. PubMed ID: 32161501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
